Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
INST Instructure Holdings Inc
TOMZ TOMI Environmental Solutions Inc
TNL Travel + Leisure Co
PSAGW Property Solutions Acquisition Corp II *W EXP 03/01/2026
AMZN Amazon.com Inc
GSK GlaxoSmithKline PLC
TSLA Tesla Inc
MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
APSG Apollo Strategic Growth Capital
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine is developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a novel biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Price
Delayed
$8.77
Day's Change
-1.28 (-12.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.07
Day's Low
8.56
Volume
(Heavy Day)

Today's volume of 36,675,139 shares is on pace to be much greater than OCGN's 10-day average volume of 31,046,379 shares.

36,675,139

Display:

Providers:

UpdateCancel
6 providers
Today's News, October 15, 2021
Thinking about buying stock in Plug Power, Cemtrex, Ocugen, NRX Pharmaceuticals, or FuelCell Energy?

InvestorsObserver issues critical PriceWatch Alerts for PLUG, CETX, OCGN, NRXP, and FCEL. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

Yesterday's News, October 14, 2021
Thinking about buying stock in Plug Power, Senseonics, Up Fintech, Waitr Holdings, or Ocugen?

InvestorsObserver issues critical PriceWatch Alerts for PLUG, SENS, TIGR, WTRH, and OCGN. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

October 13, 2021
Thinking about buying stock in DatChat, Infosys, Supernus Pharmaceuticals, FuelCell Energy, or Ocugen?

InvestorsObserver issues critical PriceWatch Alerts for DATS, INFY, SUPN, FCEL, and OCGN. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

October 12, 2021
Thinking about buying stock in Ocugen, aTyr Pharma, Nextplay Technologies, Aerie Pharmaceuticals, or Nutriband?

InvestorsObserver issues critical PriceWatch Alerts for OCGN, LIFE, NXTP, AERI, and NTRB. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

October 08, 2021
OCUGEN INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Ocugen, Inc. - OCGN

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues to investigate Ocugen, Inc. (NasdaqCM: OCGN). (BusinessWire)

October 06, 2021
Thinking about buying stock in Acer Therapeutics, Ziopharm Oncology, Nutriband, Ocugen, or Flux Power?

InvestorsObserver issues critical PriceWatch Alerts for ACER, ZIOP, NTRB, OCGN, and FLUX. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

October 05, 2021
Thinking about buying stock in Agrify, Rush Street Interactive, Ocugen, Nine Energy Service, or Ziopharm Oncology?

InvestorsObserver issues critical PriceWatch Alerts for AGFY, RSI, OCGN, NINE, and ZIOP. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

September 24, 2021
OCUGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Ocugen, Inc. - OCGN

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues to investigate Ocugen, Inc. (NasdaqCM: OCGN). (PR Newswire)

September 23, 2021
Ocugen, Inc. to Participate in Fireside Chat at the Cantor Virtual Global Healthcare Conference

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced that its Chairman, CEO, and...(Globe Newswire)

September 17, 2021
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced the Compensation...(Globe Newswire)

September 14, 2021
Thinking about buying stock in FuelCell Energy, Farmmi, Aterian, Vinco Ventures, or Ocugen?

InvestorsObserver issues critical PriceWatch Alerts for FCEL, FAMI, ATER, BBIG, and OCGN. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

September 10, 2021
OCUGEN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ocugen, Inc. - OCGN

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Ocugen, Inc. (NasdaqCM: OCGN). (BusinessWire)

September 07, 2021
Ocugen, Inc. to Present at Upcoming Citi and H.C. Wainwright Investment Conferences

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced that it will be participating in...(Globe Newswire)

August 20, 2021
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced the Compensation...(Globe Newswire)

August 17, 2021
LAWSUITS FILED AGAINST OCGN, DKNG and PLL - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods...(Accesswire)

DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 17, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocugen" or "the Company") (NASDAQ: OCGN) for...(Newsfile)

Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. (OCGN) Investors With Losses Exceeding $100K of Class Action

NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ocugen, Inc. ('Ocugen' or 'the Company') (NASDAQ:OCGN) and certain of its directors on behalf...(Accesswire)

OCGN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 17, 2021 in the Class Action Filed on Behalf of Ocugen, Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - August 17, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) alleging that the Company violated federal securities laws.(Newsfile)

OCGN FINAL DEADLINE TODAY: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 17 Deadline in Securities Class Action - OCGN

EQNX::TICKER_START EQNX::TICKER_END WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021 and June 10, 2021, inclusive (the "Class Period"), of the...(Globe Newswire)

Ocugen, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Investors with losses of $100,000 are encouraged to contact the firm before August 17, 2021; click here to submit trade information The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Ocugen, Inc. (NASDAQ...(Globe Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.